Moderna, Inc. Common Stock (MRNA) - Nasdaq
Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Moderna, Inc. Common Stock (MRNA) Real-Time Quotes - Nasdaq
Aug 30, 2024 · Get real-time updates on Moderna, Inc. Common Stock (MRNA) stock quotes, trades, and more. Make informed investments with Nasdaq.
Is Moderna a Bad-News Buy for 2025? - Nasdaq
Jan 16, 2025 · Moderna may reach its product approval and launch goals -- but this will take a few years. Meanwhile, the market could continue to sanction the biotech if sales remain lackluster in 2025.
Moderna Unusual Options Activity For January 22 - Nasdaq
3 days ago · Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular ...
Moderna, Inc. Common Stock (MRNA) Pre-Market - Nasdaq
Get the latest updates on Moderna, Inc. Common Stock (MRNA) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
A Closer Look at Moderna's Options Market Dynamics - Nasdaq
Jan 16, 2025 · Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 28 unusual trades. Delving into the details, we found 17% of traders were bullish, while 64% showed bearish tendencies.
Expert Outlook: Moderna Through The Eyes Of 19 Analysts - Nasdaq
Dec 10, 2024 · In the last three months, 19 analysts have published ratings on Moderna (NASDAQ:MRNA), offering a diverse range of perspectives from bullish to bearish.
Spotlight on Moderna: Analyzing the Surge in Options Activity
Jan 7, 2025 · Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 16 unusual trades. Delving into the details, we found 56% of traders were bullish, while 31% showed bearish tendencies.
Is Moderna Stock a No-Brainer Buy on the Sell-Off? - Nasdaq
Jan 15, 2025 · A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.
Moderna Secures $590M Funding From U.S. Government for Bird …
5 days ago · Moderna MRNA announced that the U.S. government, through the Biomedical Advanced Research and Development Authority (“BARDA”), has awarded the company $590 million to accelerate the ...